These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 610748)

  • 1. [Interaction between plasma glycoproteins and concanavalin A: shown by means of the lymphocyte transformation test. II].
    Imperato S; Manca F; Barocci S; Ciani A; Villaggio B; Margaroli GF
    Boll Soc Ital Biol Sper; 1977 Dec; 53(23):2305-9. PubMed ID: 610748
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interaction between plasma glycoproteins and concanavalin A: significance of the blastic transformation test. (I)].
    Imperato S; Manca F; Barocci S; Margaroli GF; Villaggio B; Ciani A
    Boll Soc Ital Biol Sper; 1977 Sep; 53(17):1425-30. PubMed ID: 415751
    [No Abstract]   [Full Text] [Related]  

  • 3. Glycoproteins in pregnancy serum which interact with concanavalin A and may suppress lymphocyte transformation.
    Gaugas JM
    Transplantation; 1974 Dec; 18(6):538-41. PubMed ID: 4439454
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycoprotein receptors for concanavalin A isolated from pig lymphocyte plasma membrane by affinity chromatography in sodium deoxycholate.
    Allan D; Auger J; Crumpton MJ
    Nat New Biol; 1972 Mar; 236(62):23-5. PubMed ID: 4503808
    [No Abstract]   [Full Text] [Related]  

  • 5. Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A.
    Stirpe F; Olsnes S; Pihl A
    J Biol Chem; 1980 Jul; 255(14):6947-53. PubMed ID: 7391060
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the cellular requirements for human T cell transformation by a soluble mitogen derived from Mycoplasma arthritidis and concanavalin A.
    Daynes RA; Novak JM; Cole BC
    J Immunol; 1982 Sep; 129(3):936-8. PubMed ID: 6980925
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of lidocaine in vivo to inhibit mitogen-induced lymphocyte transformation.
    Salo M; Kanto J; Jalonen J
    Ann Clin Res; 1980 Jun; 12(3):116-8. PubMed ID: 7447370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of phytohemagglutinins in oncology].
    Lutsik MD
    Vopr Onkol; 1975; 21(10):103-11. PubMed ID: 1103467
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunobiological properties of a concanavalin A derivative.
    Horowitz S; Mansfield JM; Thomasson DL; Doyle RJ
    Cell Immunol; 1978 Jun; 38(1):214-8. PubMed ID: 667956
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocyte transformation during pregnancy: an analysis using whole-blood culture.
    Yamamoto T; Hirata H; Taniguchi H; Kawai Y; Uematsu A; Sugiyama Y
    Obstet Gynecol; 1980 Feb; 55(2):215-9. PubMed ID: 6965425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of neuraminidase on the duration of contact with Con A in lymphocyte stimulation.
    Sakano T; Kittaka E; Hyodo S; Horino N; Tanaka Y; Usui T
    Hiroshima J Med Sci; 1981 Jun; 30(2):161-3. PubMed ID: 7298362
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of insulin on phytohemagglutinin-P, concanavalin-A, and pokeweed mitogen in diabetic and nondiabetic lymphocytes.
    Glassman AB; Lindsay JH; Bennett CE; Hodges ER
    Ann Clin Lab Sci; 1981; 11(1):9-14. PubMed ID: 7011167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concanavalin A-induced transformation of mononuclear cells: influence of plasma from patients receiving anti-inflammatory agents.
    Schoenberg LM; Kushner I; Khan MA
    Proc Soc Exp Biol Med; 1980 Jun; 164(2):192-5. PubMed ID: 7393924
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine metabolites suppress T cell proliferation induced by concanavalin A.
    Dindzans VJ; Wong PY; Mee AV; Cheung F; Abecassis M; Cole EH; Cohen Z; Levy GA
    Transplant Proc; 1987 Aug; 19(4):3490-3. PubMed ID: 3303521
    [No Abstract]   [Full Text] [Related]  

  • 15. [Subpopulations of human peripheral blood suppressor cells regulating lymphocyte response to different doses of concanavalin A].
    Shubinskiĭ GZ; Lozovoĭ VP
    Dokl Akad Nauk SSSR; 1980; 253(3):753-5. PubMed ID: 6448734
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of enhancement by heated serum and 2-mercaptoethanol of lymphocyte transformation induced by high concentrations of concanavalin A.
    Forsdyke DR; David CM
    Cell Immunol; 1978 Mar; 36(1):86-96. PubMed ID: 630609
    [No Abstract]   [Full Text] [Related]  

  • 17. [Functional activity of nonspecific suppressors and indicators of lymphocyte blast transformation in patients with occupational allergy].
    Dovzhanskiĭ IS
    Gig Tr Prof Zabol; 1988 Nov; (11):51-3. PubMed ID: 2976715
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sorption of a macrophage factor inducing functional thymocyte transformation on cells of organs of various sources].
    Golenishchev VIu; Anfalova TV; Galaktionov VG
    Ontogenez; 1988; 19(1):37-41. PubMed ID: 3259301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokines and thrombosis. I. Thrombocyte aggregating activity released by human lymphocytes stimulated with concanavalin-A.
    Coeugniet E; Bendixen G
    Acta Allergol; 1976 Apr; 31(2):94-106. PubMed ID: 947142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a novel Chlamydomonas mutant to demonstrate that flagellar glycoprotein movements are necessary for the expression of gliding motility.
    Bloodgood RA; Salomonsky NL
    Cell Motil Cytoskeleton; 1989; 13(1):1-8. PubMed ID: 2731235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.